Ly Mohamedou, Roubertie François, Kasdi Reda, Chatti Sana, Vergnat Mathieu, Luu David, Le Bret Emmanuel, Roussin Régine, Capderou André, Belli Emre
Department of Congenital Heart Disease, Marie Lannelongue Hospital/M3C, Paris-Sud University, Le Plessis-Robinson, France.
Department of Congenital Heart Disease, Marie Lannelongue Hospital/M3C, Paris-Sud University, Le Plessis-Robinson, France.
Ann Thorac Surg. 2014 Dec;98(6):2181-6. doi: 10.1016/j.athoracsur.2014.07.043. Epub 2014 Oct 28.
Uncommonly, adults with functionally univentricular hearts are becoming candidates for a Fontan procedure. The purpose of this study was to evaluate the course of patients undergoing the modified Fontan procedure with an extracardiac conduit in recent years.
Between January 2003 and December 2013, 32 adult patients (17 female and 15 male) underwent total cavopulmonary connection (TCPC) with extracardiac conduit. The median age at procedure was 24.5 years (interquartile range [IQR] 20 to 33 years). The diagnoses included double-inlet left ventricle (DILV) in 10 patients (31.2%), tricuspid atresia in 8 patients (25%), double-outlet right ventricle in 4 patients (12.5%), heterotaxia in 4 patients (12.5%), and mitral atresia in 2 patients (6.2%). Seventy-eight percent of patients had undergone at least one prior palliative procedure; the most common procedures were Blalock-Taussig shunt (16 patients), superior cavopulmonary shunt (12 patients), and pulmonary artery banding (6 patients). All patients underwent cardiac catheterization preoperatively. Aortic cross-clamping was necessary in 15 patients for intracardiac procedures. Fenestration was required in 9 patients (28%). Four concomitant intraoperative cryoablation procedures were performed.
There was no hospital mortality. One patient (3.1%) died 6 months after undergoing TCPC. Morbidities included prolonged pleural effusion lasting more than 7 days in 20 patients (62.5%), atrial arrhythmias in 4 patients (12.5%), and permanent pacemakers in 3 patients (9.3%). The median follow-up time was 33 months (interquartile range [IQR], 10.5 to 50 months). Actuarial survival was 91.83% (95% confidence limits, 71.07 to 97.89) at 1 year and 5 years. Ninety-two percent of patients were in New York Heart Association class I or II at follow-up. The median postoperative oxygen saturation was 95% (IQR, 93% to 95.5%). Cardiac arrhythmia occurred in 4 patients. Systolic ventricular function improved during follow-up for all patients except 1 patient, who underwent cardiac transplantation 7 months after the TCPC.
The modified Fontan procedure with use of an extracardiac conduit can be performed in adults with encouraging early and midterm results. The majority of late survivors had improved quality of life. The incidence of late death, reoperation, arrhythmias, and thromboembolic events was low during follow-up.
功能单心室的成年患者接受Fontan手术的情况并不常见。本研究的目的是评估近年来接受心外管道改良Fontan手术患者的病程。
2003年1月至2013年12月期间,32例成年患者(17例女性,15例男性)接受了心外管道全腔静脉肺动脉连接术(TCPC)。手术时的中位年龄为24.5岁(四分位间距[IQR]为20至33岁)。诊断包括双入口左心室(DILV)10例(31.2%)、三尖瓣闭锁8例(25%)、双出口右心室4例(12.5%)、内脏异位4例(12.5%)、二尖瓣闭锁2例(6.2%)。78%的患者此前至少接受过一次姑息性手术;最常见的手术是Blalock-Taussig分流术(16例)、上腔静脉肺动脉分流术(12例)和肺动脉环扎术(6例)。所有患者术前均接受了心导管检查。15例患者因心内手术需要进行主动脉阻断。9例患者(28%)需要开窗。术中进行了4例同期冷冻消融手术。
无住院死亡病例。1例患者(3.1%)在接受TCPC术后6个月死亡。并发症包括20例患者(62.5%)出现持续超过7天的胸腔积液延长、4例患者(12.5%)出现房性心律失常、3例患者(9.3%)植入永久性起搏器。中位随访时间为33个月(四分位间距[IQR]为10.5至50个月)。1年和5年的精算生存率分别为91.83%(95%置信区间为71.07至97.89)。92%的患者在随访时纽约心脏协会心功能分级为I级或II级。术后中位血氧饱和度为95%(IQR为93%至95.5%)。4例患者发生心律失常。除1例患者在TCPC术后7个月接受心脏移植外,所有患者随访期间收缩期心室功能均有所改善。
使用心外管道的改良Fontan手术可在成年患者中进行,早期和中期结果令人鼓舞。大多数晚期存活者生活质量得到改善。随访期间晚期死亡、再次手术、心律失常和血栓栓塞事件的发生率较低。